This review summarizes the complex interplay between diabetes and atrial fibrillation, emphasizing how diabetes worsens prognosis and complicates management strategies like anticoagulation and ablation.
No takes yet. Share an insight, caveat, or question.
Diabetes heightens AF-related risks; leaves open whether targeted interventions improve outcomes in prospective studies.
Pallisgaard et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: